Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and n-(6-aminohexyl)-1-naphthalenesulfonamide

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with n-(6-aminohexyl)-1-naphthalenesulfonamide in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(n-(6-aminohexyl)-1-naphthalenesulfonamide)		Trials
(n-(6-aminohexyl)-1-naphthalenesulfonamide)		Recent Studies (post-2010) (n-(6-aminohexyl)-1-naphthalenesulfonamide)
9,15618755212106

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Levy, JV1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and n-(6-aminohexyl)-1-naphthalenesulfonamide

ArticleYear
Calmodulin antagonists inhibit aggregation of human, guniea pig and rabbit platelets induced with platelet activating factor.
    FEBS letters, 1983, Apr-18, Volume: 154, Issue:2

    Topics: Animals; Calcium-Binding Proteins; Calmodulin; Dose-Response Relationship, Drug; Female; Guinea Pigs; Humans; Male; Platelet Activating Factor; Platelet Aggregation; Rabbits; Sulfonamides; Trifluoperazine

1983